Photosensitivity Clinical Trial
Official title:
The Role of Spectral Filtering in a Spectrally Adjustable Ocular Photosensitivity Analyzer
This is a 6-visit, single-center, non-dispensing, randomized, single-masked, 5×5 crossover study. Subjects will participate in 6 scheduled over the duration of approximately 10.5 months.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04520217 -
Testing Use of Topical Imipramine in Reducing Ultraviolet B Induced Microvesicle Particle Release in Photosensitive Subjects
|
Phase 1 | |
Completed |
NCT04654312 -
Study to Evaluate the Influence of Hydrochlorothiazide on Dermal Photosensitivity and DNA Stability - a Pilot Study (HCTox Study)
|
Phase 1 | |
Completed |
NCT01942564 -
The Head Injury-associated Photosensitivity and Pupillary Function (HIPP) Study
|
N/A |